The Environmental Protection Agency's (EPA) recent decision to shelve microplastics testing in U.S. drinking water has sparked intense debate and raised concerns among environmentalists and the public alike. This move comes despite the agency's earlier pledge to prioritize microplastics and pharmaceuticals as contaminants for testing, a promise made by EPA Administrator Lee Zeldin to address the growing alarm over plastics in drinking water.
The EPA's proposed rule, published in the Federal Register, indicates a five-year hiatus from requiring public water utilities to test for microplastics and pharmaceuticals. This decision is particularly striking given the European Union's established methods for testing these tiny plastic particles, which have been detected in human blood, brains, and lung tissue. California, too, has been working on its own testing protocols, a requirement mandated by a 2018 state law.
One of the key arguments against the EPA's decision is the lack of a validated and standardized method for testing microplastics in drinking water. The agency claims it cannot develop such a method before December, when testing is supposed to begin. However, this explanation has been met with skepticism, especially from environmental groups like Beyond Plastics, which suggests that the EPA should collaborate with California's water board, which has already invested significant resources in developing such a method.
The EPA's decision to exclude microplastics from the Unregulated Contaminant Monitoring Rule has also been criticized for sending mixed signals. When Zeldin announced microplastics as a priority contaminant for regulation, it seemed like a significant step towards addressing the crisis. However, by not including them in the monitoring list, the EPA has raised questions about its commitment to immediate action.
The American Chemistry Council, a trade group for chemical companies, supports the EPA's decision, arguing that national drinking water monitoring should be based on validated, standardized methods. This perspective highlights the challenge of balancing the need for comprehensive testing with limited resources and the potential for producing actionable public health information.
The public's reaction to this development has been one of frustration and resignation. Environmentalists point out the urgency of the situation, given the widespread presence of microplastics in the environment and their potential health impacts. The 60-day comment period following the plan's publication in the Federal Register will be crucial in gauging public sentiment and potentially influencing the EPA's future decisions on this issue.
